Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Association of PCSK9 plasma levels with metabolic patterns and coronary atherosclerosis in patients with stable angina ; volume:18 ; number:1 ; day:31 ; month:10 ; year:2019 ; pages:1-12 ; date:12.2019
Cardiovascular diabetology ; 18, Heft 1 (31.10.2019), 1-12, 12.2019
- Creator
-
Caselli, Chiara
Turco, Serena Del
Ragusa, Rosetta
Lorenzoni, Valentina
Graaf, Michiel De
Basta, Giuseppina
Scholte, Arthur
Caterina, Raffaele De
Neglia, Danilo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-019-0949-3
- URN
-
urn:nbn:de:101:1-2020022823060349830539
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Caselli, Chiara
- Turco, Serena Del
- Ragusa, Rosetta
- Lorenzoni, Valentina
- Graaf, Michiel De
- Basta, Giuseppina
- Scholte, Arthur
- Caterina, Raffaele De
- Neglia, Danilo
- SpringerLink (Online service)
Other Objects (12)
PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation
20. Correlation of Aortic Distensibility with Coronary Atherosclerosis in Angina Patients
Effects of PCSK9 Targeting : Alleviating Oxidation, Inflammation, and Atherosclerosis
Impact of angina frequency on health utility values of patients with chronic stable angina
Pro Percutaneous Coronary Intervention (PCI) in Patients with Stable Angina (SA)
Leptin and PCSK9 concentrations are associated with vascular endothelial cytokines in patients with stable coronary heart disease
Lower diastolic wall strain is associated with coronary revascularization in patients with stable angina
Research progress on alternative non-classical mechanisms of PCSK9 in atherosclerosis in patients with and without diabetes
Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Ivabradine in Combination with Beta-Blockers in Patients with Chronic Stable Angina After Percutaneous Coronary Intervention
Circulating expression patterns of TL1A and FFAR2 in patients with stable and unstable angina
PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation
20. Correlation of Aortic Distensibility with Coronary Atherosclerosis in Angina Patients
Effects of PCSK9 Targeting : Alleviating Oxidation, Inflammation, and Atherosclerosis
Impact of angina frequency on health utility values of patients with chronic stable angina
Pro Percutaneous Coronary Intervention (PCI) in Patients with Stable Angina (SA)
Leptin and PCSK9 concentrations are associated with vascular endothelial cytokines in patients with stable coronary heart disease
Lower diastolic wall strain is associated with coronary revascularization in patients with stable angina
Research progress on alternative non-classical mechanisms of PCSK9 in atherosclerosis in patients with and without diabetes
Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Ivabradine in Combination with Beta-Blockers in Patients with Chronic Stable Angina After Percutaneous Coronary Intervention
Circulating expression patterns of TL1A and FFAR2 in patients with stable and unstable angina
PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation
20. Correlation of Aortic Distensibility with Coronary Atherosclerosis in Angina Patients
Effects of PCSK9 Targeting : Alleviating Oxidation, Inflammation, and Atherosclerosis
Impact of angina frequency on health utility values of patients with chronic stable angina
Pro Percutaneous Coronary Intervention (PCI) in Patients with Stable Angina (SA)
Leptin and PCSK9 concentrations are associated with vascular endothelial cytokines in patients with stable coronary heart disease
Lower diastolic wall strain is associated with coronary revascularization in patients with stable angina
Research progress on alternative non-classical mechanisms of PCSK9 in atherosclerosis in patients with and without diabetes
Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
Ivabradine in Combination with Beta-Blockers in Patients with Chronic Stable Angina After Percutaneous Coronary Intervention